Literature DB >> 23393396

Long-term use of lipid-lowering drugs slows progression of carotid atherosclerosis: the Tromso study 1994 to 2008.

Marit Herder1, Kjell Arne Arntzen, Stein Harald Johnsen, Anne Elise Eggen, Ellisiv B Mathiesen.   

Abstract

OBJECTIVE: Data on the effect of lipid-lowering drugs (LLD) on carotid atherosclerosis outside clinical trials are limited. The aim of this study was to determine the effect of LLD on change in carotid intima media thickness and total plaque area in a general population. APPROACH AND
RESULTS: Subjects were 1532 women and 1442 men who participated in a longitudinal population-based study with ultrasound examination of intima media thickness and total plaque area in the right carotid artery at baseline and after 13 years follow-up. Long-term use of LLD was defined as use for >5 years, any-time use of LLD was defined as use at baseline or at 6 years or at 13 years of follow-up. In multivariable models adjusted for age, sex, systolic blood pressure, total cholesterol, high-density lipoprotein cholesterol, prevalent cardiovascular disease, and daily smoking, long-term use of LLD had a protective effect on progression of both intima media thickness (β=-0.0387 mm; P=0.002) and total plaque area (β=-0.400 mm(2); P=0.006). There was a weaker protective effect of any-time use of LLD on progression of intima media thickness (β=-0.024 mm; P=0.046) and total plaque area (β=-0.318 mm(2); P=0.06).
CONCLUSIONS: LLD protected against progression of carotid atherosclerosis. The protective effect was strongest in long-term users.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23393396     DOI: 10.1161/ATVBAHA.112.300767

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  8 in total

1.  Carotid atherosclerosis and cardiovascular health metrics in old subjects from the AGES-Reykjavik study.

Authors:  Ran Sturlaugsdottir; Thor Aspelund; Gudlaug Bjornsdottir; Sigurdur Sigurdsson; Gudny Eiriksdottir; Cindy Mari Imai; Melissa Garcia; Lenore J Launer; Tamara B Harris; Vilmundur Gudnason
Journal:  Atherosclerosis       Date:  2015-06-27       Impact factor: 5.162

Review 2.  Atherosclerosis.

Authors:  Hong Lu; Alan Daugherty
Journal:  Arterioscler Thromb Vasc Biol       Date:  2015-03       Impact factor: 8.311

3.  Pathophysiology and Medical Treatment of Carotid Artery Stenosis.

Authors:  Kailash Prasad
Journal:  Int J Angiol       Date:  2015-06-23

Review 4.  Cardiovascular Immunotherapy and the Role of Imaging.

Authors:  Eva Zupančič; Zahi A Fayad; Willem J M Mulder
Journal:  Arterioscler Thromb Vasc Biol       Date:  2017-11       Impact factor: 8.311

5.  Modifiable risk factors for carotid atherosclerosis: a meta-analysis and systematic review.

Authors:  Xi Ji; Xin-Yi Leng; Yi Dong; Ya-Hui Ma; Wei Xu; Xi-Peng Cao; Xiao-He Hou; Qiang Dong; Lan Tan; Jin-Tai Yu
Journal:  Ann Transl Med       Date:  2019-11

6.  The association between autonomic dysfunction, inflammation and atherosclerosis in men under investigation for carotid plaques.

Authors:  Marcus A Ulleryd; Ulrica Prahl; Johannes Börsbo; Caroline Schmidt; Staffan Nilsson; Göran Bergström; Maria E Johansson
Journal:  PLoS One       Date:  2017-04-04       Impact factor: 3.240

Review 7.  Symptomatic Carotid Artery Stenosis: Surgery, Stenting, or Medical Therapy?

Authors:  Ashley M Wabnitz; Tanya N Turan
Journal:  Curr Treat Options Cardiovasc Med       Date:  2017-08

8.  Clusters of Cardiometabolic Risk Factors and Their Association with Atherosclerosis and Chronic Inflammation among Adults and Elderly in Florianópolis, Southern Brazil.

Authors:  Tiago Rodrigues de Lima; Diego Augusto Santos Silva; Maruí Weber Corseuil Giehl; Eleonora D'Orsi; David Alejandro González-Chica
Journal:  Arq Bras Cardiol       Date:  2021-07       Impact factor: 2.000

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.